SEC Form 4 · accession 0001209191-15-038608
CELGENE CORP /DE/ · CELG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Perry A Karsen
Officer — see remarks
Period of report
Apr 30, 2015
Accepted (ET)
May 4, 2015 · 7:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816284
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 30, 2015 | M | 11,200 | $0.00 | A | 85,330 | D | |
| Common Stock | Apr 30, 2015 | F | 5,807 | $108.06 | D | 79,523 | D | |
| Common Stock | holding | — | — | — | 1,639 | I | 401(k) Plan | |
| Common Stock | holding | — | — | — | 2,000 | I | IRA Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2,F1 | — | Apr 30, 2015 | M | 11,200 | D | — | — | Common Stock | 11,200 | 0 | D |
| Stock Option (right to buy)F4,F3 | $109.90 | May 4, 2015 | A | 12,125 | A | — | May 4, 2025 | Common Stock | 12,125 | 12,125 | D |
Explanation of responses
- F1All of the restricted stock units granted to the reporting person on April 30, 2012 vested and settled for shares of the Company's common stock.
- F2The restricted stock units were issued pursuant to the Company's 2008 Stock Incentive Plan (as Amended and Restated as of April 17, 2013). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- F3Option is immediately exercisable and will vest in four equal annual installments commencing on May 4, 2016.
- F4The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as Amended and Restated as of April 17, 2013).
Remarks
Chief Executive Officer of Celgene Cellular Therapeutics